11Natco Pharma
Natco Introduces Semaglutide at Rs 1,290: A New Era for Diabetes Treatment
Natco Pharma launches semaglutide at Rs 1,290, aiming to make diabetes treatment more accessible and reshape the weight-loss drug market in India.
Comprehensive Trading Guide for Bharat Electronics and Other Stocks
Discover effective trading strategies for Bharat Electronics, Natco Pharma, and more as market volatility impacts stock prices.